{
    "clinical_study": {
        "@rank": "89007", 
        "brief_summary": {
            "textblock": "Chemotherapy and radiation therapy for the treatment of cancer can compromise fertility.\n      Ovarian tissue cryopreservation is an experimental strategy offered at The University of\n      Pennsylvania to preserve future fertility (protocol 806062). The primary objective of this\n      study is to determine the efficacy and safety of autologous transplantation of previously\n      cryopreserved ovarian cortical tissue in patients who experience infertility or ovarian\n      insufficiency after cancer treatments."
        }, 
        "brief_title": "Ovarian Tissue Transplantation", 
        "completion_date": {
            "#text": "June 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertile Females or Females With Ovarian Insufficiency", 
        "condition_browse": {
            "mesh_term": [
                "Infertility", 
                "Menopause, Premature", 
                "Primary Ovarian Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female patient between the ages of 18 and 45 years\n\n          -  Previously cryopreserved and stored cortical ovarian tissue available for autologous\n             transplantation\n\n          -  Ovarian insufficiency defined as an elevated FSH over 10\n\n          -  Inability to conceive after 6 months of unprotected intercourse with male\n\n          -  Reasonably good health\n\n          -  Candidate for pregnancy\n\n          -  Written clearance for the procedure from the patients oncologist\n\n        Exclusion Criteria:\n\n          -  Patients considered to be high risk for surgical complications will be excluded from\n             the research protocol\n\n          -  Women who are known to be positive for the BRCA mutation\n\n          -  Women with a history of leukemia, ovarian cancer or a cancer that likely involved the\n             ovaries at the time of ovarian tissue collection\n\n          -  Women with psychological, psychiatric, or other conditions which prevent giving fully\n             informed consent\n\n          -  Current pregnancy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01870752", 
            "org_study_id": "UPCC 02813"
        }, 
        "intervention": {
            "intervention_name": "Chemotherapy", 
            "intervention_type": "Radiation"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 4, 2013", 
        "location": {
            "contact": {
                "last_name": "Clarisa Gracia, MD", 
                "phone": "877-204-9213"
            }, 
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19104"
                }, 
                "name": "Abramson Cancer Center of the University of Pennsylvania"
            }, 
            "investigator": {
                "last_name": "Clarisa Gracia, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Autologous Orthotopic Transplantation of Previously Cryopreserved Ovarian Tissue", 
        "overall_contact": {
            "email": "PennCancerTrials@emergingmed.com", 
            "last_name": "Clarisa Gracia, MD", 
            "phone": "877-204-9213"
        }, 
        "overall_official": {
            "affiliation": "Abramson Cancer Center of the University of Pennsylvania", 
            "last_name": "Clarisa R Gracia, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of Adverse Events", 
            "safety_issue": "Yes", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01870752"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Abramson Cancer Center of the University of Pennsylvania", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abramson Cancer Center of the University of Pennsylvania", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}